|
| Press Releases |
|
 |
|
| Monday, June 27, 2022 |
|
|
醫思健康榮獲《機構投資者》2022亞洲區最佳管理團隊多個獎項 |
| 香港最大非醫院醫療服務機構* ── 醫思健康（「公司」，連同附屬公司，總稱「集團」；香港聯交所股份編號：2138）欣然公佈集團於國際金融權威雜誌《機構投資者》發布的2022年度「亞洲區最佳管理團隊」榜單中榮獲醫療健康及製藥類別多個獎項。 more info >> |
|
|
EC Healthcare Received "Institutional Investor" 2022 Multiple Awards in All-Asia Executive Team Rankings |
| EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong* more info >> |
|
| Thursday, June 23, 2022 |
|
|
医思健康公布2021/22年度全年业绩 |
| 香港最大非医院医疗服务机构* ── 医思健康（「公司」，连同附属公司，总称「集团」；香港联交所股份编号：2138）公布截至2022年3月31日止财政年度（「年内」）之经审核全年业绩。 more info >> |
|
|
醫思健康公佈2021/22年度全年業績 |
| 香港最大非醫院醫療服務機構* ── 醫思健康（「公司」，連同附屬公司，總稱「集團」；香港聯交所股份編號：2138）公佈截至2022年3月31日止財政年度（「年內」）之經審核全年業績。 more info >> |
|
|
EC Healthcare Announces FY2021/22 Annual Results |
EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong, announces today its audited annual results for the fiscal year ended 31 March 2022 (the "Year").
more info >> |
|
| Tuesday, June 21, 2022 |
|
|
醫思健康訂立可持續發展表現掛鈎雙重貸款 開創香港醫療健康市場先河 |
| 香港最大非醫院醫療服務機構*──醫思健康（「公司」，連同附屬公司，總稱「集團」；香港聯交所股份編號：2138）欣然宣佈，集團首次訂立可持續發展表現掛鈎貸款（「可持續發展貸款」），總值為7億港元。 more info >> |
|
|
EC Healthcare Signs Inaugural Dual-Tranche Sustainability-Linked Facility, The First-of-its-Kind in Hong Kong Healthcare Industry |
| EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong* more info >> |
|
| Monday, June 6, 2022 |
|
|
医思健康携手凯龙瑞及亚洲联合基建成立合资公司 |
| 香港最大非医院医疗服务机构*──医思健康（「公司」，连同附属公司，统称「集团」；香港联交所股份编号：2138）欣然宣布，集团与房地产投资管理公司凯龙瑞集团（「凯龙瑞」）及亚洲联合基建控股有限公司（「亚洲联合基建」；香港联交所股份编号：0711）成立合资公司（「合资公司」） more info >> |
|
|
醫思健康攜手凱龍瑞及亞洲聯合基建成立合資公司 |
| 香港最大非醫院醫療服務機構*──醫思健康（「公司」，連同附屬公司，統稱「集團」；香港聯交所股份編號：2138）欣然宣佈，集團與房地產投資管理公司凱龍瑞集團（「凱龍瑞」）及亞洲聯合基建控股有限公司（「亞洲聯合基建」；香港聯交所股份編號：0711）成立合資公司（「合資公司」） more info >> |
|
|
EC Healthcare Forms a Joint Venture with KaiLong and Asia Allied Infrastructure |
| EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the Group formed a joint venture company (the "JV Company") with a real estate investment management company more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Elevating Possibilities: The Countdown for WBS Dubai Begins!
Apr 16, 2024 23:33 HKT/SGT
|
|
|
Lexaria Receives Ethics Review Board Approval to Begin New GLP-1 Study
Apr 16, 2024 21:10 HKT/SGT
|
|
|
CleverTap bags ten prestigious awards at the 2024 Stevie Awards
Apr 16, 2024 20:00: JST
|
|
|
InnoEX, Spring Electronics Fair boost tech hub status
Apr 16, 2024 19:24 HKT/SGT
|
|
|
CleverTap bags ten prestigious awards at the 2024 Stevie Awards
Apr 16, 2024 19:00 HKT/SGT
|
|
|
益美国际拓展国际绿能布局，盈利前景广阔可期
Apr 16, 2024 18:11 HKT/SGT
|
|
|
益美國際拓展國際綠能佈局，盈利前景廣闊可期
Apr 16, 2024 18:08 HKT/SGT
|
|
|
LEXUS、ミラノデザインウィーク2024に出展
Apr 16, 2024 18:00: JST
|
|
|
Lexus presents Time at the 2024 Milan Design Week
Apr 16, 2024 18:49 JST
|
|
|
中国抗体SM17治疗特应性皮炎（AD）之临床前结果刊登于国际科学期刊《Allergy》
Apr 16, 2024 17:48 HKT/SGT
|
|
|
中國抗體SM17治療特應性皮炎（AD）之臨床前結果刊登於國際科學期刊《Allergy》
Apr 16, 2024 17:44 HKT/SGT
|
|
|
SinoMab BioScience preclinical results of SM17 on atopic dermatitis (AD) published on International Scientific Journal Allergy
Apr 16, 2024 17:35 HKT/SGT
|
|
|
Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment Technology
Apr 16, 2024 17:04 HKT/SGT
|
|
|
三菱商事、米国ルイジアナ州におけるDACプロジェクトへの参画について
Apr 16, 2024 14:00: JST
|
|
|
NEC、SBTiからNet-Zero目標の認定を取得
Apr 16, 2024 14:00: JST
|
|
|
|
|
More News >> |
|
|
|
|
|
